2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3 ...
Version 1.2 3 Patients' inhaler technique should be checked to make sure that aerosol actuation is synchronised with inspiration of breath for optimum delivery of the medicine to the lungs.
Download 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3 ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
MDI VALVES AND ACTUATORS - Bespak
www.bespak.com• The valve is the most technically complex element in an MDI, and critical to delivering a consistent and precise metered dose of medication to users
Asmol CFC-free inhaler - Medicines.org.au
www.medicines.org.auAsmol inhaler – Product Information 2 CLINICAL TRIALS Salbutamol, delivered from a pressurised metered-dose inhaler using chlorofluorocarbon (CFC) propellants, has been used for over 20 years in clinical practice and has been demonstrated to be safe and
1. PRODUCT NAME 2. QUALITATIVE AND QUANTITATIVE …
www.medsafe.govt.nz1 . NEW ZEALAND DATA SHEET . 1. PRODUCT NAME FLIXOTIDE Inhaler (CFC-Free) 50 micrograms/dose, aerosol inhaler, metered dose. FLIXOTIDE Inhaler (CFC-Free) 125 micrograms/dose, aerosol inhaler, metered
Public Assessment Report Decentralised Procedure Combisal ...
www.mhra.gov.ukPAR Combisal 25/50, 25/125 and 25/250 microgram per metered dose pressurised inhaler, suspension UK/H/6076//001-003/DC 5 For the full list of all side effects reported with Combisal, see …
Validation of a Questionnaire for Assessing Adherence to ...
www.neumologia-pediatrica.comherence can cause therapeutic failure, need to increase medication dosage or add other medications, need for costly diagnostic testing, and unnecessary morbidity and even mortality.1,2 Self-report of asthma medication use by the patient (or by parents or caregivers in the case of children)
Principles of Metered-Dose Inhaler Design
www.rcjournal.comIntroduction: Development of the Pressurized Metered-Dose Inhaler In the first half of the 20th century, inhaled drugs for the treatment of asthma and chronic obstructive pulmonary
Hydrofluoroalkane as a propellant for pressurized metered ...
www.scielo.brHydrofluoroalkane as a propellant for inhalers Œ Ibiapina CC et alii Jornal de Pediatria - Vol. 80, No.6, 2004 443 evaluated 18 adult patients for six weeks, compared the efficiency of …